In patients with MDS and AML, mutations in SRSF2 frequently co-occur with mutations in genes such as IDH2, RUNX1, TET2, STAG2, and ASXL1 [1, 4, 8]. Here, RUNX1 is linked to myelodysplastic syndrome.